Navigation Links
New Research Could Expand Availability of Light-Based Mesothelioma Therapy, According to Surviving Mesothelioma

Raleigh, NC (PRWEB) July 14, 2014

The NIH is giving $8 million dollars to researchers at the University of Pennsylvania to fund a clinical trial on light-based therapy in mesothelioma surgical patients. Click here to read Surviving Mesothelioma’s newly-posted article on the research.

Scientists at the University of Pennsylvania plan to use the grant to enroll 102 pleural mesothelioma study participants over the next four years. Patients will receive a photosensitizing drug prior to surgery. Then half will have the laser light treatment during their procedure while half will have only follow-up chemotherapy.

“This trial represents a major step in understanding the combination of treatment modalities that will offer patients the best hope for survival and extended remission,” said lead investigator Eli Glatstein, MD.

Previous University of Pennsylvania studies of PDT with lung-sparing surgery have produced remarkable survival rates of up to 41 months, even in patients with advanced mesothelioma.

“PDT is an exciting emerging therapy that is currently not widely available for mesothelioma treatment,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “If the results of these new NIH-funded studies are as encouraging as the previous studies of PDT at Penn, more patients who need it may get access to this therapy.”

For details of the new PDT research at Penn, see NIH Grant May Help Validate Light-Based Therapy for Mesothelioma now available on the Surviving Mesothelioma website.

“Penn Mesothelioma Program Receives $8 Million NCI Grant to Study Effects of Photodynamic Therapy Plus Surgery on Patient Survival and Disease Progression”, July 10, 2014, News Release, University of Pennsylvania website,

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stanford researchers invent nanotech microchip to diagnose type-1 diabetes
2. Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld
3. Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at
4. Casinos in Australia Industry Market Research Report Now Updated by IBISWorld
5. Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated
6. World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at
7. Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld
8. Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld
9. Researchers Assess New Way to Boost Polio Immunity
10. USC stem cell researcher targets the seeds of breast cancer metastasis
11. Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... 7th Annual 2015 Golden Bridge Business Awards under the New Products and Services ... capex web based sample management software that helps labs organize data ...
(Date:12/1/2015)... ... 01, 2015 , ... For many X-rays taken at hospitals, ... interpretation by the radiologist. The marking utensils are so small, however, they are ... a way to alleviate this problem. , He developed the patent-pending MARK N ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, ... been awarded a fixed price per sprint agile development contract to support the ... million over five years, provides software engineering, infrastructure, as well as operations and ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech North ... Gary has spent a significant amount of time in Sweden since joining PartnerTech ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani ... Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled ... Contact Center solutions targeted to the high-end enterprise contact center marketplace. , Ed ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: